BAC

Bank of America Corporation

60
Fundamentals72/ 100
Valuation55/ 100
Upside potential71/ 100
Risk potential10/ 100

BAC's fundamentals are strong: its operating margin rose 5 points to 35% and revenue grew 15%. At 12x earnings, it's trading in line with its usual 13x. Analysts expect earnings growth.

CCAQ

Collective Acquisition Corp.

There isn't enough reported data to score CCAQ yet.

BAC Fundamentals

MetricStatus
Healthy
Strong
N/A
N/A

BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.

CCAQ Fundamentals

MetricStatus
Unavailable
Stable
N/A
N/A

CCAQ's profitability is currently stable. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like CCAQ.

BAC PE Valuation

CHEAPFAIREXPENSIVE5.6x11x17x22x
CHEAPFAIREXPENSIVE5.6x11x17x22x
LevelPEPriceVs current
Cheap9.4x$39.50-22%
Forward10x$50.51—
Current12x$50.51—
Fair13x$53.81+6.5%
Expensive15x$62.23+23%

Historical ranges are pointers, not guarantees.

BAC has the edge over CCAQ in the historical PE scenario, which offers more potential upside but is not a forecast.

CCAQ PE Valuation

CHEAPFAIREXPENSIVE79x158x237x316x
CHEAPFAIREXPENSIVE79x158x237x316x
LevelPEPriceVs current
Cheap57x$3.42-68%
Fair63x$3.79-64%
Current179x$10.68—
Expensive302x$18.09+69%

Historical ranges are pointers, not guarantees.

CCAQ's PE is 179x, but its earnings don't support one, so it isn't a reliable read right now.

BAC Forward outlook

MetricOutlook
Improving
Growth
Growth
Strongly improving
Limited
Moderate

Analysts expect earnings and revenue growth for BAC, with profitability improving.

CCAQ Forward outlook

There aren't enough analyst estimates for CCAQ to show an outlook.

BAC Risk to reward

ScenarioChangePrice
Upside+25%$63.36
Downside-10%$45.36

Calculated from the latest close: $50.51 on Nov 12.

There is not enough scenario data to compare BAC and CCAQ's risk to reward.

CCAQ Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $10.68 on Nov 12.

There is not enough scenario data to compare BAC and CCAQ's risk to reward.

BAC Earnings Per Share

Q4 2023: $3.08Q1 2024: $2.90Q2 2024: $2.85Q3 2024: $2.76Q4 2024: $3.21Q1 2025: $3.35Q2 2025: $3.41Q3 2025: $3.66Q4 2025: $3.81Q1 2026: $4.02Q2 2026: $4.34Q3 2026: $4.19Forward: $4.92
Q4 2023: $3.08Q1 2024: $2.90Q2 2024: $2.85Q3 2024: $2.76Q4 2024: $3.21Q1 2025: $3.35Q2 2025: $3.41Q3 2025: $3.66Q4 2025: $3.81Q1 2026: $4.02Q2 2026: $4.34Q3 2026: $4.19Forward: $4.92
QuarterTTM EPSYoY
Forward$4.92+17%
Q3 2026$4.19+14%
Q2 2026$4.34+27%
Q1 2026$4.02+20%
Q4 2025$3.81+19%
Q3 2025$3.66+33%
Q2 2025$3.41+20%
Q1 2025$3.35+16%
Q4 2024$3.21+4.2%

BAC has the edge over CCAQ in the latest year-over-year earnings comparison.

CCAQ Earnings Per Share

Q2 2025: $0.03Q3 2025: $0.10Q4 2025: $0.17Q1 2026: $0.20Q2 2026: $0.19Q3 2026: $0.06
Q2 2025: $0.03Q3 2025: $0.10Q4 2025: $0.17Q1 2026: $0.20Q2 2026: $0.19Q3 2026: $0.06
QuarterTTM EPSYoY
Q3 2026$0.06-40%
Q2 2026$0.19+533%

CCAQ earned $0.06 per share over the past year, down 40% from the year before.

BAC Quarterly Revenue

Q4 2023: $22BQ1 2024: $25.8BQ2 2024: $25.4BQ3 2024: $25.3BQ4 2024: $25.3BQ1 2025: $27.4BQ2 2025: $26.5BQ3 2025: $28.1BQ4 2025: $31.2BQ1 2026: $30.3BQ2 2026: $31.6BQ3 2026: $30B
Q4 2023: $22BQ1 2024: $25.8BQ2 2024: $25.4BQ3 2024: $25.3BQ4 2024: $25.3BQ1 2025: $27.4BQ2 2025: $26.5BQ3 2025: $28.1BQ4 2025: $31.2BQ1 2026: $30.3BQ2 2026: $31.6BQ3 2026: $30B
QuarterRevenueYoY
Q3 2026$30B+6.7%
Q2 2026$31.6B+19%
Q1 2026$30.3B+11%
Q4 2025$31.2B+23%
Q3 2025$28.1B+11%
Q2 2025$26.5B+4.3%
Q1 2025$27.4B+6%
Q4 2024$25.3B+15%

BAC has the edge over CCAQ on sales, with more consistent year-over-year improvement.

CCAQ Quarterly Revenue

Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0Q3 2026: --
Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0Q3 2026: --

CCAQ's revenue is shrinking: $0 last quarter.

BAC Free Cash Flow

Q4 2023: $32.7BQ1 2024: −$15.5BQ2 2024: $18.1BQ3 2024: −$37.3BQ4 2024: $25.9BQ1 2025: −$2.2BQ2 2025: −$9.1BQ3 2025: $46.9BQ4 2025: −$22.9BQ1 2026: $41.8BQ2 2026: $29BQ3 2026: −$6.5B
Q4 2023: $32.7BQ1 2024: −$15.5BQ2 2024: $18.1BQ3 2024: −$37.3BQ4 2024: $25.9BQ1 2025: −$2.2BQ2 2025: −$9.1BQ3 2025: $46.9BQ4 2025: −$22.9BQ1 2026: $41.8BQ2 2026: $29BQ3 2026: −$6.5B
QuarterFree cash flowYoY
Q3 2026-$6.5B-114%
Q2 2026$29B+$38.2B
Q1 2026$41.8B+$44B
Q4 2025-$22.9B-189%
Q3 2025$46.9B+$84.2B
Q2 2025-$9.1B-150%
Q1 2025-$2.2B+$13.4B
Q4 2024$25.9B-21%

BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.

CCAQ Free Cash Flow

Q3 2024: --Q4 2024: −$30,470Q1 2025: −$14,862Q2 2025: −$190,247Q3 2025: --Q4 2025: −$36,150Q1 2026: --Q2 2026: −$285,958Q3 2026: −$156,201
Q3 2024: --Q4 2024: −$30,470Q1 2025: −$14,862Q2 2025: −$190,247Q3 2025: --Q4 2025: −$36,150Q1 2026: --Q2 2026: −$285,958Q3 2026: −$156,201
QuarterFree cash flowYoY
Q2 2026-$286K-$95.7K
Q4 2025-$36.2K-$5.7K

CCAQ and BAC do not have enough comparable growth data to identify a winner.

BAC Total Shares

Q4 2023: 8.1BQ1 2024: 8BQ2 2024: 8BQ3 2024: 7.9BQ4 2024: 7.9BQ1 2025: 7.8BQ2 2025: 7.7BQ3 2025: 7.6BQ4 2025: 7.7BQ1 2026: 7.4BQ2 2026: 7.3BQ3 2026: 7.2B
Q4 2023: 8.1BQ1 2024: 8BQ2 2024: 8BQ3 2024: 7.9BQ4 2024: 7.9BQ1 2025: 7.8BQ2 2025: 7.7BQ3 2025: 7.6BQ4 2025: 7.7BQ1 2026: 7.4BQ2 2026: 7.3BQ3 2026: 7.2B
PeriodChange %Net change
Quarterly-1%-72M shares
1 year-5.3%-405M shares
3 years-11%-854M shares
5 years-15%-1.3B shares
Available history-24%-2.2B shares

BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.

CCAQ Total Shares

Q3 2024: 18MQ4 2024: 18MQ1 2025: 18MQ2 2025: 20MQ3 2025: 20MQ4 2025: 20MQ1 2026: 20MQ2 2026: 14MQ3 2026: 7M
Q3 2024: 18MQ4 2024: 18MQ1 2025: 18MQ2 2025: 20MQ3 2025: 20MQ4 2025: 20MQ1 2026: 20MQ2 2026: 14MQ3 2026: 7M
PeriodChange %Net change
Quarterly-49%-7M shares
1 year-64%-12.9M shares

CCAQ has the edge over BAC on shareholder dilution, with a more favorable share count trend.

BAC Net Leverage

Q4 2023: 9.5xQ1 2024: 9.5xQ2 2024: 9.4xQ3 2024: 9.9xQ4 2024: 9.0xQ1 2025: 8.6xQ2 2025: 8.8xQ3 2025: 8.3xQ4 2025: 7.7xQ1 2026: 7.1xQ2 2026: 6.7xQ3 2026: 6.4x
Q4 2023: 9.5xQ1 2024: 9.5xQ2 2024: 9.4xQ3 2024: 9.9xQ4 2024: 9.0xQ1 2025: 8.6xQ2 2025: 8.8xQ3 2025: 8.3xQ4 2025: 7.7xQ1 2026: 7.1xQ2 2026: 6.7xQ3 2026: 6.4x
QuarterNet LeverageStatus
Q3 20266.4xHigh
Q2 20266.7xHigh
Q1 20267.1xHigh
Q4 20257.7xHigh
Q3 20258.3xHigh
Q2 20258.8xHigh
Q1 20258.6xHigh
Q4 20249.0xHigh

BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.

CCAQ Net Leverage

BAC Weekly Momentum

MetricValueStatus
RSI37.1Neutral
Stochastic4.9Oversold

BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).

CCAQ Weekly Momentum

MetricValueStatus
RSI65.8Neutral
Stochastic43.1Neutral

CCAQ's weekly RSI is 66 (neutral) and its Stochastic is 43 (neutral).

BAC PE vs Financial Services Sector

MetricBACSector medianRelative
PE12x13x7.5% below
PE %406323 pts below

BAC has the edge over CCAQ on valuation relative to its sector.

CCAQ PE vs Financial Services Sector

MetricCCAQSector medianRelative
PE179x13x1,276% above
PE %781266 pts above

CCAQ is trading at 179x earnings, a 1276% premium to the Financial Services sector's median of 13x, though its earnings don't support one.

BAC Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$52.13% below
20 week MA$57.813% below
50 week MA$54.77.7% below
100 week MA$50.50% below
200 week MA$42.519% above

CCAQ has stronger trend alignment. BAC is above 1 of 5 weekly averages versus CCAQ above 3 of 3.

CCAQ Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$10.60.5% above
20 week MA$10.61% above
50 week MA$10.42.5% above

CCAQ is in an uptrend: it's above all three of its weekly moving averages, and 2.5% above its 50-week average.

BAC Yearly ROI

YearStart priceEnd priceROI
2020$35.4$30.0-15%
2021$30.0$44.4+48%
2022$44.4$32.5-27%
2023$32.5$33.7+3.7%
2024$33.7$44.3+32%
2025$44.3$56.2+27%
2026 YTD$56.2$50.5-10%

BAC has finished higher in four of the last six years. It's down 10% so far in 2026.

CCAQ Yearly ROI

YearStart priceEnd priceROI
2025$10.0$10.2+1.7%
2026 YTD$10.2$10.7+4.8%

CCAQ has the edge over BAC on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key